Prevalence of Chronic Airway Obstruction in Subjects With a History of Cigarette Smoking in a Primary Care Setting
Public ClinicalTrials.gov record NCT01013948. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prevalence of Chronic Airway Onstruction in a Subject Population With a History of Cigarette Smoking in a Primary Care Setting
Study identification
- NCT ID
- NCT01013948
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- GlaxoSmithKline
- Industry
- Enrollment
- 1,574 participants
Conditions and interventions
Conditions
Interventions
- Non-Interventional Other
Other
Eligibility (public fields only)
- Age range
- 30 Years to 87 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2009
- Primary completion
- Apr 30, 2009
- Completion
- Apr 30, 2009
- Last update posted
- Oct 17, 2012
2009
United States locations
- U.S. sites
- 40
- U.S. states
- 14
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Investigational Site | Adamsville | Alabama | 35005 | — |
| GSK Investigational Site | Foothill Ranch | California | 92610 | — |
| GSK Investigational Site | Huntington Beach | California | 92647 | — |
| GSK Investigational Site | Los Gatos | California | 95032 | — |
| GSK Investigational Site | Rolling Hills Estate | California | 90274 | — |
| GSK Investigational Site | San Francisco | California | 94102 | — |
| GSK Investigational Site | Solana Beach | California | 92075 | — |
| GSK Investigational Site | Torrance | California | 90505 | — |
| GSK Investigational Site | Torrance/California | California | 90505 | — |
| GSK Investigational Site | Tulare | California | 93274 | — |
| GSK Investigational Site | Altmonte Springs | Florida | 32714 | — |
| GSK Investigational Site | Belle Glade | Florida | 33430 | — |
| GSK Investigational Site | Green Cove Springs | Florida | 32043 | — |
| GSK Investigational Site | Jacksonville | Florida | 32277 | — |
| GSK Investigational Site | Oviedo | Florida | 32765 | — |
| GSK Investigational Site | Sebastian | Florida | 32958 | — |
| GSK Investigational Site | Conyers | Georgia | 30094 | — |
| GSK Investigational Site | Snellville | Georgia | 30039 | — |
| GSK Investigational Site | Northbrook | Illinois | 60062 | — |
| GSK Investigational Site | Vernon Hills | Illinois | 60061 | — |
| GSK Investigational Site | Louisville | Kentucky | 40222 | — |
| GSK Investigational Site | Williamsburg | Kentucky | 40769 | — |
| GSK Investigational Site | Reisterstown | Maryland | 21136 | — |
| GSK Investigational Site | West Plains | Missouri | 65775 | — |
| GSK Investigational Site | Brick | New Jersey | '08723 | — |
| GSK Investigational Site | Elmhurst | New York | 11373 | — |
| GSK Investigational Site | Manhasset | New York | 11030 | — |
| GSK Investigational Site | Cleveland | Ohio | 44113 | — |
| GSK Investigational Site | Cortland | Ohio | 44410 | — |
| GSK Investigational Site | Lansdowne | Pennsylvania | 19050 | — |
| GSK Investigational Site | Philadelphia | Pennsylvania | 19103 | — |
| GSK Investigational Site | Greenville | South Carolina | 29601 | — |
| GSK Investigational Site | Austin | Texas | 78745 | — |
| GSK Investigational Site | Flower Mound | Texas | 75028 | — |
| GSK Investigational Site | Grand Prairie | Texas | 75052 | — |
| GSK Investigational Site | Houston | Texas | 77089 | — |
| GSK Investigational Site | Irving | Texas | 75061 | — |
| GSK Investigational Site | Lake Jackson | Texas | 77566 | — |
| GSK Investigational Site | Plano | Texas | 75093 | — |
| GSK Investigational Site | Richardson | Texas | 75080 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01013948, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 17, 2012 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01013948 live on ClinicalTrials.gov.